Tag: Fisher & Paykel

WASHINGTON – Medicare’s bid surety bond requirement did not have a negative impact on small supplier participation in Round 2021 of the competitive bidding, says the Government Accountability Office in a new report.  For the report, “Effect of New Bid Surety Bond Requirement on Small Supplier Participation in the Competitive Bidding Program,” the GAO reviewed CMS’ data on supplier bids and contracts, and interviewed two DME trade organizations, including AAHomecare,...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported revenue of $583 million for the first four months of its financial year 2022.   Seventy-four percent of that revenue came from F&P’s hospital group during the four-month time period, which ended July 31. Constant currency revenue was 3% below the prior comparable period. This consisted of a 13% decline in hardware sales, partially offset by 2% growth in consumables.   The company’s hospital consumables sales...

YARMOUTH, Maine – Manufacturers like ResMed and 3B Medical are ramping up production to meet increased demand due to a voluntary recall of millions of Philips CPAP devices, but their efforts are complicated by supply chain and other challenges.  “Yes, we’re ramping up production as quickly as possible, while working closely with our global supplier network to navigate the well-known global supply chain challenges impacting this and other industries,” said Jayme...

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported operating revenue of $1.97 billion for the full year ended March 31, 2021, an increase of 56% over the previous year or 61% in constant currency.  The company reported net profit after tax was $524 million, an increase of 82% or 94% in constant currency.  “The unprecedented result was driven by our Hospital product group, which includes Optiflow and Airvo systems used to deliver nasal...

IRVINE, Calif. - Fisher & Paykel Healthcare saw lower diagnosis rates of obstructive sleep apnea globally for the first four months of its fiscal year 2021 but mildly elevated rates of mask resupply, the company stated in a recent update.The company saw 4% revenue growth for masks for the first four months of FY21 compared to the prior comparable period.Still, “we have maintained our assumption that OSA diagnosis rates are reduced for the year,” F&P stated in the update.Overall, thanks...

IRVINE, Calif. - Fisher & Paykel Healthcare saw lower diagnosis rates of obstructive sleep apnea globally for the first four months of its fiscal year 2021 but mildly elevated rates of mask resupply, the company stated in a recent update.The company saw 4% revenue growth for masks for the first four months of FY21 compared to the prior comparable period.Still, “we have maintained our assumption that OSA diagnosis rates are reduced for the year,” F&P stated in the update.Overall, thanks...

IRVINE, Calif. - Fisher & Paykel Healthcare has hired about 600 additional manufacturing staff in New Zealand and more than 500 in Mexico, according to the New Zealand Herald. Lewis Gradon, managing director and CEO, told the newspaper the company first started ramping up hiring in February and plans to continue to add staff through the end of the year in both New Zealand and Mexico. “We do constantly grow, just not at that kind of rate in manufacturing,” he told the newspaper. “(Without...

AUCKLAND, New Zealand - Fisher & Paykel has received regulatory clearance for its F&P Evora nasal mask in the United States. The mask features CapFit headgear, which is designed for patients to put on like a baseball cap. In a clinical trial, 98% of patients said it was simple to put on and take off in the dark. The Evora also features a “floating” seal, which sits inside stability wings, allowing for freedom of movement during sleep while keeping the mask comfortably in place.

IRVINE, Calif. - Fisher & Paykel Healthcare has updated its revenue and earnings guidance for the financial year ended March 31, 2020, due to better-than-expected sales in its home care product group.“We've seen better-than-expected sales in our home care product group combined with continued strong growth in our hospital product group,” said Lewis Gradon, managing director and CEO. “This includes an increase in demand from China related to the COVID-19 coronavirus outbreak.”F&P...

WASHINGTON - Taxpayers could see nearly $5.9 billion that has been misspent on healthcare services returned to the government, according to The Office of Inspector General in its Semiannual Report to Congress published last week.Of the savings and recoveries in FY 2019, more than $819 million is expected to be recovered from audits and approximately $5.04 billion from investigative recoveries, according to the OIG.For the reporting period, April 1- Sept. 30, 2019, the OIG reported 353 criminal and...